M. Belkaid

Independent Impact of Iron Overload and Transfusion Dependency on Survival and Leukemic Evolution in Patients with Myelodysplastic Syndrome

L. Arenillas, M. Tormo, J. Cervera, 2008 .

Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?

E. Campo, D. Costa, M. Rozman, 2010, Leukemia research.

Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support

A. Carrió, D. Costa, M. Rozman, 2011, American journal of hematology.

Hematopoiesis-related microRNA expression in myelodysplastic syndromes

E. Montserrat, M. Rozman, A. Navarro, 2009, Leukemia & lymphoma.